ORIC Oric Pharmaceuticals, Inc.: institutional ownership and insider trading
189 funds reported holding $1.43B of Oric Pharmaceuticals, Inc. in their latest 13F filings; in Q2 2026 funds net bought $49.2M, with 28 new positions and 30 funds selling out; over the last 12 months insiders bought $0 and sold $2.96M on the open market.
Famous investors holding ORIC
- Andreas Halvorsen (Viking Global Investors): $55.5M, 0.2% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $17.1M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $28.4M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $7.56M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $6.54M, 0.0% of the portfolio
Largest institutional holders of ORIC
- Nextech Invest, Ltd. — $77.6M
- BlackRock, Inc. (BLK) — $73.9M
- EcoR1 Capital, LLC — $72.9M
- PRICE T ROWE ASSOCIATES INC /MD/ — $71.7M
- VIKING GLOBAL INVESTORS LP — $55.5M
- STATE STREET CORP (STT, STT-PG) — $53.0M
- SR ONE CAPITAL MANAGEMENT, LP — $50.0M
- VR Adviser, LLC — $46.8M
- NEA Management Company, LLC — $44.6M
- VANGUARD CAPITAL MANAGEMENT LLC — $42.8M
Recent ORIC insider trades
- Oct 20, 2026: Piscitelli Dominic sold 14,000 shares ($189K)
- Oct 1, 2026: Heyman Richard A. sold 6,700 shares ($86.5K)
- Sep 28, 2026: Piscitelli Dominic sold 13,400 shares ($181K)
- Sep 24, 2026: Piscitelli Dominic sold 600 shares ($8.11K)
5%+ owners
- VIKING GLOBAL INVESTORS LP: 7.8% (Schedule 13G/A, filed May 15, 2026)
- T. Rowe Price Associates, Inc.: 5.4% (Schedule 13G, filed May 15, 2026)